Lars Thorsson Email

VP Clinical Development . Cantargia AB

Current Roles

Employees:
38
Revenue:
$5.9M
About
Cantargia develops antibody based therapy against the target IL1RAP. The lead candidate CAN04 is for treatment of solid tumors and hematoligacal cancers, entering phase I/IIa clinical development.
Cantargia AB Address
Medicon Village
Lund, null
Cantargia AB Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.